Shimere Sherwood

American Society of Clinical Oncology Statement: Biosimilars in Oncology.

R. Schilsky, G. Lyman, A. Tsao, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology.

K. Viswanath, R. Herbst, A. Alberg, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.

J. Taube, M. Oberley, R. Herbst, 2022, JCO precision oncology.

Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.

R. Schilsky, S. Bruinooge, S. Grubbs, 2019, Journal of oncology practice.

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

K. Wilner, G. Lyman, Caroline Schenkel, 2021, Clinical Cancer Research.

ASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology

J. Vose, G. Lyman, F. Cardoso, 2023, JCO oncology practice.

Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology.

K. Viswanath, R. Herbst, A. Alberg, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.